Press Releases

Read: BioMed X Advances Women’s Health Innovation at Inaugural XFem Labs Pitch & Connect Event

BioMed X Advances Women’s Health Innovation at Inaugural XFem Labs Pitch & Connect Event

• Feb 17, 2026

Read: BioMed X Appoints Former Max Planck Institute Head of Administration Nico Frisch as Vice President, Site Head Heidelberg

BioMed X Appoints Former Max Planck Institute Head of Administration Nico Frisch as Vice President, Site Head Heidelberg

• Feb 4, 2026

Read: BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

• Jan 27, 2026

Read: BioMed X Launches XBridge Pilot to Facilitate Industry-Academic Research Collaborations

BioMed X Launches XBridge Pilot to Facilitate Industry-Academic Research Collaborations

• Jan 13, 2026

Read: BioMed X Announces New Neuroscience Research Collaboration in the USA

BioMed X Announces New Neuroscience Research Collaboration in the USA

• Nov 25, 2025

Read: New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute Heidelberg

New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute Heidelberg

• Oct 23, 2025

Read: BioMed X launches Women’s Health R&D Accelerator in Heidelberg

BioMed X launches Women’s Health R&D Accelerator in Heidelberg

• Oct 14, 2025

Read: BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery

BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery

• Aug 19, 2025

Read: BioMed X and Servier Launch First XSeed Labs in Europe

BioMed X and Servier Launch First XSeed Labs in Europe

• Jul 9, 2025

Read: BioMed X and Boehringer Ingelheim Expand Joint XSeed Labs Incubator in the U.S.

BioMed X and Boehringer Ingelheim Expand Joint XSeed Labs Incubator in the U.S.

• May 20, 2025

Read: BioMed X Launches XBridge Program to Support Biomedical Researchers Impacted by NIH Funding Gaps

BioMed X Launches XBridge Program to Support Biomedical Researchers Impacted by NIH Funding Gaps

• Apr 7, 2025

Read: AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations

AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations

• Mar 5, 2025

Read: BioMed X Launches New Institute in Barbados

BioMed X Launches New Institute in Barbados

• Feb 20, 2025

Read: BioMed X and Merck Successfully Complete Extrachromosomal DNA in Cancer Research Project

BioMed X and Merck Successfully Complete Extrachromosomal DNA in Cancer Research Project

• Feb 6, 2025

Read: BioMed X Launches New Collaboration with Daiichi Sankyo in Cancer Therapy

BioMed X Launches New Collaboration with Daiichi Sankyo in Cancer Therapy

• Jan 14, 2025

Read: New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at the BioMed X Institute Heidelberg

New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at the BioMed X Institute Heidelberg

• Sep 17, 2024

Read: BioMed X Start Collaboration in Autoimmunity Research with Servier

BioMed X Start Collaboration in Autoimmunity Research with Servier

• Jun 26, 2024

Read: BioMed X Launches New US Institute in New Haven, CT

BioMed X Launches New US Institute in New Haven, CT

• Jun 13, 2024

Read: BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project

BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project

• May 28, 2024

Read: New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration with Boehringer Ingelheim

New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration with Boehringer Ingelheim

• May 16, 2024

Read: New Immuno-Oncology Research Project in Partnership with Merck Starts at the BioMed X Institute Heidelberg

New Immuno-Oncology Research Project in Partnership with Merck Starts at the BioMed X Institute Heidelberg

• Apr 30, 2024